Phathom sets October 29 results as Jefferies cuts target to Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Phathom Pharmaceuticals has scheduled its third-quarter results webcast for October 29, 2026, at 8:00 a.m. EDT. Jefferies recently lowered its price target for Phathom stock from USD 20.00 to USD 16.00, while maintaining a Buy rating. The company also announced three scientific presentations related to VOQUEZNA and highlighted cost-effectiveness data.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · AD HOC NEWS · · AI-summarised by FinFlash
Phathom Pharmaceuticals has scheduled its third-quarter results webcast for October 29, 2026, at 8:00 a.m. EDT. Jefferies recently lowered its price target for Phathom stock from USD 20.00 to USD 16.00, while maintaining a Buy rating. The company also announced three scientific presentations related to VOQUEZNA and highlighted cost-effectiveness data.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.